Healthcare -
Biotechnology - NASDAQ - US
$ 313.0
-2.2 %
$ 14.1 B
Market Cap
12.7
P/E
UTHR - OPERATING INCOME
Operating Income UTHR - United Therapeutics Corporation
1.18 B
LAST VALUE
46.00%
2 YEAR CAGR
8.03%
5 YEAR CAGR
15.02%
10 YEAR CAGR